Availability, Cost, and Consumer Ratings of Popular Nonvalidated vs Validated Blood Pressure-Measuring Devices Sold Online in 10 Countries

Dean S Picone; Niamh Chapman; Martin G Schultz; Aletta E Schutte; George S Stergiou; Paul K Whelton; James E Sharman

doi:10.1001/jama.2023.2661

Availability, Cost, and Consumer Ratings of Popular Nonvalidated vs Validated Blood Pressure-Measuring Devices Sold Online in 10 Countries

JAMA. 2023 May 2;329(17):1514-1516. doi: 10.1001/jama.2023.2661.

Authors

Dean S Picone¹, Niamh Chapman¹, Martin G Schultz¹, Aletta E Schutte², George S Stergiou³, Paul K Whelton⁴, James E Sharman¹

Affiliations

¹ Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia.
² School of Population Health, University of New South Wales, Sydney, Australia.
³ Hypertension Center STRIDE-7, National and Kapodistrian University of Athens, Athens, Greece.
⁴ Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana.

No abstract available

Plain language summary

This study examines the availability, cost, and consumer ratings of blood pressure–measuring devices relative to validation status across 10 countries.

MeSH terms

Blood Pressure
Blood Pressure Monitoring, Ambulatory* / economics
Blood Pressure Monitoring, Ambulatory* / instrumentation
Blood Pressure Monitoring, Ambulatory* / standards
Consumer Behavior* / economics
Costs and Cost Analysis
Internationality
Internet / economics